Oncternal Therapeutics, Inc. (ONCT) Q1 2021 Earnings Call Transcript
Joining me on the call this afternoon are our president and CEO, Dr. James Breitmeyer; and our acting CMO, Dr. Today's call includes a business update and discussion of our 2021 first-quarter financial results which will be followed by Q&A. Today's press release and replay of today's earnings call will be available on the Investor Relations section of Oncternal's website for at least the next 30 days.